Prescripción de medicamentos oncológicos en un Servicio de Oncología : adecuación a las guías de práctica clínica
Fecha
2016-11
Título de la revista
ISSN de la revista
Título del volumen
Editor
Sociedad Española de Farmacia Hospitalaria
Resumen
Descripción
Resumen
Objetivo: Evaluar la prescripción de medicamentos oncológicos
de la Red de Salud Pública Municipal de Rosario según su adecuación
las guías de práctica clínica.
Método: Estudio farmacoepidemiológico descriptivo en pacientes
adultos en un Servicio Oncológico. Enero-junio 2012.
Se evaluó la adecuación de las prescripciones a las guías de
práctica clínica de referencia.
Resultados: El 51,8 % de los diagnósticos tuvo al menos un
medicamento prescripto que no coincidía con lo recomendado
por al menos una de las guías consideradas. Las prescripciones
de doxorrubicina e ifosfamida no coincidieron con lo recomendado
por ninguna guía. El 5,4% de las prescripciones no estaban
consideradas en las guías locales, el 7,7% no lo estaban
en las nacionales y, respecto de las internacionales, el 4,2 %
no estaban consideradas en la European Society for Medical
Oncology, el 2,3% por el American Cancer Society y solo el
1,9% por la National Comprehensive Cancer Network.
Conclusiones: La prescripción de oncológicos se adecúa más a
las guías internacionales. Podría deberse a que no existe aún
una definición estándar en el manejo de las patologías tumorales
por parte del Estado Nacional.
Abstract Objective: To assess prescription of oncology medications in municipal public health network of Rosario for its appropriateness to clinical practice guidelines. Methods: Descriptive pharmacoepidemiological study in adult patients in an Oncology Service between January and June 2012. Compliance requirements with clinical practice guidelines were evaluated. Results: 51.8% of diagnoses had at least one prescription medication that did not match recommendation by at least one of the guides considered. Prescriptions of doxorrubicine and ifosfamide did not agree with the recommendation of any reference guides. 5.4% of prescriptions weren´t considered by local guides, nor 7.7% by national on es. Regarding comparison with international guidelines: 4.2% of prescriptions weren ´t considered by the European Society for Medical Oncology guidelines, 2.3% not considered by the American Cancer Society and only 1.9% were not considered by the National Comprehensive Cancer Network ones. Conclusions: Prescription of oncology treatments is closer to international reference guides. One reason could be that there is still no standard definition in the management of tumor diseases by the National State.
Abstract Objective: To assess prescription of oncology medications in municipal public health network of Rosario for its appropriateness to clinical practice guidelines. Methods: Descriptive pharmacoepidemiological study in adult patients in an Oncology Service between January and June 2012. Compliance requirements with clinical practice guidelines were evaluated. Results: 51.8% of diagnoses had at least one prescription medication that did not match recommendation by at least one of the guides considered. Prescriptions of doxorrubicine and ifosfamide did not agree with the recommendation of any reference guides. 5.4% of prescriptions weren´t considered by local guides, nor 7.7% by national on es. Regarding comparison with international guidelines: 4.2% of prescriptions weren ´t considered by the European Society for Medical Oncology guidelines, 2.3% not considered by the American Cancer Society and only 1.9% were not considered by the National Comprehensive Cancer Network ones. Conclusions: Prescription of oncology treatments is closer to international reference guides. One reason could be that there is still no standard definition in the management of tumor diseases by the National State.
Palabras clave
Medicamentos oncológicos, Farmacoepidemiología, Guía de practica clínica, Oncology medication, Clinical practice guideline, Pharmacoepidemiology